Evox Therapeutics
PrivateLast Round
Series C
Feb 18, 2021
Total Funding Raised
$168.25M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Evox Therapeutics operates in Healthcare & Life Sciences and is based in Oxford. Its latest recorded funding round was a Series C round in February 2021.
Evox Therapeutics is a biotechnology company that develops exosome-based therapeutics for the treatment of severe rare, neurological, and neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Evox Therapeutics Comparables
Compare Evox Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ILIAS Biologics Inc. | 84% | |
| EXO Biologics | 77% | |
| VivaZome Therapeutics | 77% |
For institutional investors. Book with your work email.
Evox Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Feb 18, 2021 | ||||
| Convertible Debt | Jun 9, 2020 | ||||
| Grant | Mar 22, 2019 | ||||
| Grant | Nov 13, 2018 | ||||
| Grant | Oct 1, 2018 | ||||
Series B | Sep 3, 2018 |
For institutional investors. Book with your work email.
Evox Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Redmile Group | Series B, Series C |
| Innovate UK | Grant |
| UK government | Grant |
| GV | Series B, Series C |
| Cowen Private Investments | Series B, Series C |
| Duchenne UK | Grant |
| Oxford Science Enterprises | Series B, Series C, Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 100% MoM to 5.5K.
- Mar 22, 2019
$2M grant received from Innovate UK and UK government.
For institutional investors. Book with your work email.
Evox Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Evox Therapeutics's valuation, stock price, and market status.
Is Evox Therapeutics a public or private company?
Evox Therapeutics is a private company.
What is the current stock price of Evox Therapeutics?
Evox Therapeutics is a private company, so its shares have no public market price. Caplight tracks Evox Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Evox Therapeutics worth (valuation)?
Valuation information for Evox Therapeutics is not publicly available.
Can I buy Evox Therapeutics stock?
Evox Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Evox Therapeutics's last funding round?
Evox Therapeutics's most recent funding round was Series C on February 18, 2021.
Who are the main investors in Evox Therapeutics?
Key investors in Evox Therapeutics include Redmile Group, Oxford Science Enterprises.
Will Evox Therapeutics IPO soon?
No public IPO plans have been announced for Evox Therapeutics.
How can I track Evox Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Evox Therapeutics's shares on secondary markets.